A modern pod system using nicotine salts from a non–Big Tobacco company has been authorised by the US Food and Drug Administration (FDA) through the premarket tobacco product application (PMTA) pathway.
The landmark decision for Njoy’s Ace closed e-cigarette device and three accompanying tobacco-flavoured e-liquid pods represents two firsts: the first modern system using nicotine salts and the first time a company from outside the Big Tobacco sphere has been granted a PMTA.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
LATEST ALERTS
